Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 40, Issue 11, Pages 2437-2442Publisher
SPRINGER
DOI: 10.1007/s10096-021-04245-y
Keywords
Varicella-zoster virus; Encephalitis; Meningitis; Prognosis
Categories
Ask authors/readers for more resources
This study investigated a total of 36 adult patients hospitalized for varicella-zoster virus (VZV) meningitis or encephalitis in one referral center from 2000 to 2015. Age was the only variable associated with adverse outcomes, with no patient deaths but 33% of patients experiencing neurological sequelae at discharge.
We conducted an observational retrospective study of all adults hospitalized for documented varicella-zoster virus (VZV) meningitis or encephalitis during years 2000-2015 in one referral centre. Thirty-six patients (21 males, 15 females) were included, with meningitis (n = 21), or meningoencephalitis (n = 15). Median age was 51 years [interquartile range, 35-76], and 6 patients (17%) were immunocompromised. Aciclovir was started in 32 patients (89%), with a median dose of 11 mg/kg/8 h [10-15]. No patient died, but 12 (33%) had neurological sequelae at discharge. Age was the only variable associated with adverse outcome (OR 1.98 [1.17-3.35] per 10-year increment, P = 0.011).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available